CHARLES SCHWAB INVESTMENT MANAGEMENT INC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 39 filers reported holding NEOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$14,000
+16.7%
21,0900.0%0.00%
Q3 2020$12,000
-20.0%
21,0900.0%0.00%
Q2 2020$15,000
-6.2%
21,0900.0%0.00%
Q1 2020$16,000
-50.0%
21,0900.0%0.00%
Q4 2019$32,0000.0%21,0900.0%0.00%
Q3 2019$32,000
+14.3%
21,0900.0%0.00%
Q2 2019$28,000
-90.7%
21,090
-81.8%
0.00%
Q1 2019$302,000
+93.6%
115,620
+22.3%
0.00%
Q4 2018$156,000
-42.9%
94,530
+68.2%
0.00%
Q3 2018$273,000
-22.4%
56,2000.0%0.00%
Q2 2018$352,000
-3.0%
56,200
+28.6%
0.00%
Q1 2018$363,000
-18.6%
43,7000.0%0.00%
Q4 2017$446,000
+11.5%
43,7000.0%0.00%
Q3 2017$400,000
+25.0%
43,7000.0%0.00%
Q2 2017$320,000
+106.5%
43,700
+103.3%
0.00%
Q1 2017$155,000
+23.0%
21,5000.0%0.00%
Q4 2016$126,000
-11.3%
21,5000.0%0.00%
Q3 2016$142,000
-29.0%
21,5000.0%0.00%
Q2 2016$200,00021,5000.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DSC Advisors, L.P. 784,704$5,163,0003.14%
WALL STREET ASSOCIATES 149,343$983,0000.34%
DAFNA Capital Management LLC 38,873$256,0000.18%
Perceptive Advisors 330,593$2,175,0000.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 229,166$1,508,0000.07%
FALCON POINT CAPITAL, LLC 69,135$408,0000.06%
Cormorant Asset Management, LP 50,613$333,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 80,000$526,0000.01%
FRANKLIN RESOURCES INC 1,314,700$8,650,0000.01%
PUTNAM INVESTMENTS LLC 215,000$1,415,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders